Breaking News Instant updates and real-time market news.

PI

Impinj

$38.08

-1.49 (-3.77%)

04:55
09/14/17
09/14
04:55
09/14/17
04:55

Impinj management to meet with Pacific Crest

Meeting to be held in New York on September 14 hosted by Pacific Crest.

  • 14

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 14

    Nov

  • 15

    Nov

PI Impinj
$38.08

-1.49 (-3.77%)

06/27/17
06/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Impinj (PI) was downgraded to Sector Weight from Overweight by Pacific Crest analyst Brad Erickson based on valuation. 2. Mizuho analyst Haendel St. Juste downgraded Store Capital (STOR) to Neutral from Buy citing fair valuation following recent strength driven by Berkshire Hathaway's (BRK.A) investment. 3. Camtek (CAMT) was downgraded to Hold from Buy by Needham analyst Y. Edwin Mok, as he expects to see some deceleration as the PCB business normalizes and he believes large orders for back-end semi inspections are already reflected in the stock after its recent run-up. 4. Nomura Instinet analyst Dan Dolev downgraded Cintas (CTAS) to Neutral from Buy after lowering his FY18 uniform rental organic growth forecasts to 5% from 7%. 5. Atlantic Equities analyst Barry MacCarthy downgraded Hess Corp. (HES) and Schlumberger (SLB), both to Neutral from Overweight, given his view of the limited prospects for an oil price rebound. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
ADAM
08/04/17
NO CHANGE
Target $50
ADAM
Buy
Impinj price target lowered to $50 from $57 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target on Impinj to $50 from $57 following Q2 results and lowered guidance. The analyst noted delayed rollouts with a handful of customers in different verticals, including retail and healthcare, and said a single customer could represent several million endpoint IC's. Management maintained its long-term guidance and Walkley expects re-accelerating revenue growth in 2018 and beyond. As a results, Walkley maintained his Buy rating on Impinj shares.
08/23/17
DOTC
08/23/17
INITIATION
Target $62
DOTC
Buy
Impinj initiated with a Buy at Dougherty
Dougherty started Impinj with a Buy rating and $62 price target.
08/23/17
KEYB
08/23/17
NO CHANGE
KEYB
Sector Weight
Much uncertainty remains around Impinj pushouts, says KeyBanc
KeyBanc analyst Brad Erickson says that given the potential number of customers materially impacted by Impinj's (PI) 2H outlook, he continues to lack clarity on what drove the simultaneous delays across several tag IC end users. Nonetheless, the analyst still believes RFID adoption is rising, which keeps his general long-term thesis intact. Based on his conversation with Amazon's (AMZN) principal engineer at the RAIN RFID Alliance in Seattle, the Amazon bull case of tens of billions of units could be in play longer-term. With that said, he is equally as convinced that Amazon may not be a massive buyer of tag ICs for the foreseeable future. He reiterates a Sector Weight rating on Impinj's shares.

TODAY'S FREE FLY STORIES

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

07:33
09/25/17
09/25
07:33
09/25/17
07:33
Hot Stocks
Spark Therapeutics appoints Dr. Federico Mingozzi as Chief Scientific Officer »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

AGN

Allergan

$204.65

1.99 (0.98%)

07:32
09/25/17
09/25
07:32
09/25/17
07:32
Hot Stocks
Allergan announces new $2B share repurchase plan, affirms guidance »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ECA

Encana

$11.25

-0.05 (-0.44%)

07:31
09/25/17
09/25
07:31
09/25/17
07:31
Recommendations
Encana analyst commentary  »

Encana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Allergan »

Allergan announces new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

, ROK

Rockwell Automation

$177.55

0.22 (0.12%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

ROK

Rockwell Automation

$177.55

0.22 (0.12%)

DVA

DaVita

$57.49

-3.77 (-6.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

NTDOY

Nintendo

$45.62

-0.98 (-2.10%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

07:29
09/25/17
09/25
07:29
09/25/17
07:29
Periodicals
Nintendo adds two-factor authentication for accounts, the Verge says »

Nintendo (NTDOY) users…

NTDOY

Nintendo

$45.62

-0.98 (-2.10%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

EGO

Eldorado Gold

$2.26

0.02 (0.89%)

07:29
09/25/17
09/25
07:29
09/25/17
07:29
Upgrade
Eldorado Gold rating change  »

Eldorado Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

APRN

Blue Apron

$5.19

-0.04 (-0.76%)

07:28
09/25/17
09/25
07:28
09/25/17
07:28
Initiation
Blue Apron initiated  »

Blue Apron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$188.30

0.39 (0.21%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$51.60

4.8 (10.26%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27
Recommendations
Cubic analyst commentary  »

Cubic price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$30.05

-0.05 (-0.17%)

07:26
09/25/17
09/25
07:26
09/25/17
07:26
Periodicals
Corning looks to expand Gorilla presence in auto glass market, DigiTimes says »

Corning is looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:26
09/25/17
09/25
07:26
09/25/17
07:26
General news
Futures pointing to slightly lower open »

Stock futures are trading…

ALSSF

Alsea

$3.53

-0.1382 (-3.77%)

07:25
09/25/17
09/25
07:25
09/25/17
07:25
Upgrade
Alsea rating change  »

Alsea upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAA

STAAR Surgical

$10.90

0.05 (0.46%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Upgrade
STAAR Surgical rating change  »

STAAR Surgical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.32

0.24 (2.64%)

07:24
09/25/17
09/25
07:24
09/25/17
07:24
Technical Analysis
Technical View: Transocean trades higher in pre-market, analyst action »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

ZG

Zillow

$38.93

-0.93 (-2.33%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Initiation
Zillow initiated  »

Zillow initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

AMAT

Applied Materials

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Applied Materials analyst commentary  »

Applied Materials analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

AEM

Agnico Eagle

$46.74

0.6 (1.30%)

07:23
09/25/17
09/25
07:23
09/25/17
07:23
Recommendations
Agnico Eagle analyst commentary  »

Agnico Eagle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

DK

Delek US

$25.70

0.25 (0.98%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Conference/Events
Delek US management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

APOP

Cellect Biotechnology

$8.28

0.19 (2.35%)

07:22
09/25/17
09/25
07:22
09/25/17
07:22
Recommendations
Cellect Biotechnology analyst commentary  »

Cellect Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPX

Louisiana-Pacific

$28.44

0.53 (1.90%)

07:21
09/25/17
09/25
07:21
09/25/17
07:21
Recommendations
Louisiana-Pacific analyst commentary  »

Louisiana-Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSO

CytoSorbents

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Hot Stocks
CytoSorbents highlights publication of study in Journal of Artificial Organs »

CytoSorbents highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRMD

CorMedix

$0.47

0.048 (11.37%)

07:20
09/25/17
09/25
07:20
09/25/17
07:20
Recommendations
CorMedix analyst commentary  »

CorMedix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
09/25/17
09/25
07:20
09/25/17
07:20
General news
FX Update: The euro has come under across-the-board pressure »

FX Update: The euro has…

TWTR

Twitter

$17.61

0.03 (0.17%)

07:19
09/25/17
09/25
07:19
09/25/17
07:19
Periodicals
Twitter tests Twitter Lite Android app in the Philippines, TechCrunch says »

Twitter is testing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.